The proportion of children vaccinated within the National Immunisation Programme (NIP) has fallen for the second year in a row. This is according to the report ‘Vaccination coverage and annual report of the Dutch National Immunisation Programme for 2022’. RIVM is concerned about this decline.

According to RIVM’s registration system, at least 90% of babies have been vaccinated against mumps, measles and rubella (MMR). Furthermore, around 93% of babies are registered as having been vaccinated against diphtheria, pertussis (whooping cough), tetanus and polio (DTaP-IPV). The registration system shows that more than 50% of boys have now had their first vaccination against HPV. The same is true for more than 60% of girls.

In early 2023, 1.3 million young adults will receive an invitation to get vaccinated against the human papillomavirus (HPV). This group comprises around 900,000 men and 400,000 women between the ages of 19 and 27.

In 2021, fewer people contracted diseases for which vaccines are offered under the National Immunisation Programme (NIP) than before the coronavirus pandemic. This is very likely largely due to the impact of the coronavirus measures, such as social distancing and hand washing.

Last year, the Netherlands Pharmacovigilance Centre Lareb received 1,462 reports of possible side effects from vaccines administered under the National Immunisation Programme. As was the case in previous years, no new, disconcerting side effects have

Participation in the National Immunisation Programme has fallen slightly, showing a decrease of 1 to 2 percentage points. During the COVID-19 pandemic, the staff of Youth Healthcare Services made considerable efforts to reach

RIVM research shows that the vaccine against meningococci protects against all pathogenic forms of the meningococcus bacteria (types W, C and Y).

Participation in the vaccinations against mumps, measles and rubella (MMR) and diphtheria, pertussis (whooping cough), tetanus and polio) (DTaP-IPV) has decreased slightly among infants (-1%).